-
Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer
04 Feb 2025 22:22 GMT
… limited-stage small cell lung cancer. If approved, these … in combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond treatment …
-
Drug-Eluting Beads Bronchial Arterial Chemoembolization Combined with Immunotherapy Resulted in Pathological Complete Response of Squamous Cell Lung Cancer: A Case Report
18 Dec 2024 16:06 GMT
… candidate drug for treating lung cancer. Importantly, epirubicin … arterial chemoembolization in lung cancer patients with hemoptysis. … pathologic assessment of lung cancer resection specimens after … gemcitabine for treatment of non-small cell lung cancer. …
-
Verastem Oncology Provides a Clinical Update for RAMP 203 Trial in Advanced KRAS G12C Mutant Non-Small Cell Lung Cancer
18 Dec 2024 12:41 GMT
… mutant advanced non-small cell lung cancer (NSCLC). No dose-limiting … mutant non-small cell lung cancer.”
RAMP 203 Clinical Update … G12C mutant non-small cell lung cancer (NSCLC) who have … avutometinib and defactinib with gemcitabine/nab-paclitaxel in …
-
AstraZeneca's Imfinzi receives US FDA approval to treat patients with limited─stage small cell lung cancer
06 Dec 2024 04:06 GMT
… extensive-stage small cell lung cancer, underscoring our commitment … combination with chemotherapy (gemcitabine plus cisplatin) in … portfolio includes leading lung cancer medicines and the … improvements for people with lung cancer, including and beyond …
-
IMFINZI® (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer
05 Dec 2024 12:23 GMT
… Notes
Small cell lung cancer
Lung cancer is the leading … combination with chemotherapy (gemcitabine plus cisplatin) in … for people with lung cancer, including and beyond … lung-cancer-101/types-of-lung-cancer.
American Cancer Society. Small cell lung cancer …
-
Understanding Lung Cancer Stages And Making Informed Treatment Decisions
13 Nov 2024 13:54 GMT
… types of lung cancers are non-small cell lung cancer and small cell lung cancer. Dr … drugs used in lung cancer (NSCLC) are cisplatin, etoposide, carboplatin, gemcitabine, and paclitaxel …
-
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
28 Oct 2024 10:49 GMT
… lung cancer have significantly improved in recent years, lung cancer … -009.
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … protein-bound, or gemcitabine and carboplatin) were …
-
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
24 Sep 2024 12:00 GMT
… STK11 mutant non-small cell lung cancer (NSCLC). The initial goal of … the standard of care of gemcitabine + nab-paclitaxel suggesting potential complementary …
-
Imfinzi Shows Significant Survival Benefits in Limited-Stage Small-Cell Lung Cancer in Phase III ADRIATIC Trial
13 Sep 2024 17:25 GMT
… NSCLC; in combination with gemcitabine plus cisplatin to treat … chemoradiotherapy may prime the lung tumor microenvironment for sensitivity to … subtypes of small-cell lung cancer, and the investigation of … resectable non-small cell lung cancer before and after …
-
Impact of Chemotherapy on Circulating Lymphocyte Subsets in Lung Cancer Patients
10 Sep 2024 04:28 GMT
… lung cancer, myelosuppression, peripheral blood, lymphocyte subsets
Introduction
Lung cancer … lymphocyte subsets in lung cancer patients undergoing … small cell lung cancer. Transll Lung Cancer Res. 2024 … Combinatorial immunotherapy with gemcitabine and ex vivo …